Related Experiment Video
Updated: Jul 27, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 10, 2014
Drug transporters in HIV Therapy
1Division of Clinical Pharmacology at Vanderbilt University School of Medicine, Nashville, TN, USA.
Summary
Drug transporters like P-glycoprotein significantly impact HIV protease inhibitor (PI) drug levels and effectiveness. Inhibiting these transporters can improve PI central nervous system (CNS) penetration, but may also increase toxicity risks.
Area of Science:
- Pharmacology
- Molecular Biology
- HIV Therapeutics
Background:
- Drug transporter proteins, particularly P-glycoprotein, are critical in determining the disposition and efficacy of medications.
- P-glycoprotein influences the oral bioavailability and central nervous system (CNS) penetration of protease inhibitors (PIs), key drugs in HIV treatment.
- Genetic variations (polymorphisms) in the MDR1 gene, which regulates P-glycoprotein, are linked to variations in PI plasma levels and treatment outcomes.
Purpose of the Study:
- To explore the role of drug transporters, specifically P-glycoprotein, in the pharmacokinetics and pharmacodynamics of antiretroviral drugs.
- To discuss the potential of targeting P-glycoprotein with inhibitors to enhance the therapeutic benefits of protease inhibitors.
- To review the implications of transporter activity and inhibition on drug toxicity, including hepatotoxicity.
Main Methods:
- Review of existing literature and data on P-glycoprotein function and its impact on antiretroviral drugs.
- Analysis of studies investigating the effects of P-glycoprotein inhibitors on drug penetration and efficacy.
- Examination of research linking MDR1 gene polymorphisms to drug disposition and clinical outcomes in HIV patients.
Main Results:
- P-glycoprotein significantly limits the CNS penetration of protease inhibitors; potent inhibitors can substantially increase this penetration.
- MDR1 gene polymorphisms correlate with varying plasma PI concentrations and differences in CD4+ cell count recovery.
- Inhibition of drug transporters, while potentially beneficial for drug delivery, carries risks of increased adverse drug effects, such as hepatotoxicity.
Conclusions:
- Modulating drug transporter activity presents a promising strategy for optimizing antiretroviral therapy, potentially improving treatment efficacy and patient outcomes.
- Further research is necessary to fully understand and safely exploit the therapeutic potential of targeting drug transporters in HIV management.
- Careful consideration of transporter inhibition is crucial to mitigate risks of adverse drug reactions and ensure patient safety.
More Related Videos
12:03Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Related Concept Videos
01:31Membrane Transporters
Transporters are essential membrane transport proteins with functions related to cell nutrition, homeostasis, communication, etc. Approximately 7% of all genes in the human genome code for transporters or transporter-related proteins.
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
01:19Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
01:06Carrier-Mediated Transport
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
01:14Active Transport
Active transport is a critical biological process that allows cells to move solutes against an electrochemical gradient. This process requires direct energy input and is characterized by its selectivity, saturability, and susceptibility to competitive inhibition.
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
01:14Hepatic Drug Clearance: Role of Transporters
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...